Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma - Wikidata - awgldk - TriplyDB

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

http://www.wikidata.org/entity/Q24236589

about

High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin's lymphoma: a systematic review.Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis.Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer.Tailored strategies for radiation therapy in classical Hodgkin's lymphoma.Contribution of three-dimensional conformal intensity-modulated radiation therapy for women affected by bulky stage II supradiaphragmatic Hodgkin disease.Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.Increased risk of second lung cancer in Hodgkin's lymphoma survivors: a meta-analysis.XVII. Radiotherapy in early stage Hodgkin lymphoma.Role of modern radiation therapy in early stage Hodgkin's lymphoma: A young radiation oncologists' perspective.Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma.Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials.Disparities in survival by insurance status in patients with Hodgkin lymphoma.Early-stage nodular lymphocyte-predominant Hodgkin lymphoma: the impact of radiotherapy on overall survival.The case for combined-modality therapy for limited-stage Hodgkin's disease.Pharmacokinetics of dacarbazine (DTIC) in pregnancy.

P2860

Q24235563-05DEE991-7506-4B69-8D2D-2C93CDBC68E2 Q30937299-341F5DB5-F6B1-43D7-A237-B14395BEB142 Q34284202-0E40050F-DBFC-4205-A8C3-8D503E60EECE Q34483455-FDDDCA7F-DD67-4A92-981D-951082DAA1A7 Q34610653-2F8A9C72-0887-4E0C-A791-FC76AB49769C Q36898355-06D7285F-2954-4728-9060-E3C2733B0825 Q37383554-66101CCC-526F-4EBC-AD5C-E4ACF7F9D1F1 Q37598106-9E8FC065-FD0C-4E0C-82C0-EEF2C76B29B9 Q38051051-7C8B2AD6-78CB-44EA-A6AF-3DA068E59E48 Q38115238-F4D0E210-473E-46EF-91F7-665548C67BCD Q38199495-1F0BF602-FFE5-47CC-B148-48790C96E21B Q38559153-92327E89-F655-40C6-9D2B-0278A2FA4EC2 Q38817696-A839FC59-0CC4-45D6-A302-3117A056CB17 Q40040274-6C1D1390-CDBB-4902-B416-427C5E60654E Q40853433-15999937-41DA-424C-A555-FA355032C8D7 Q41335670-FAF74CE1-AB0D-4FCC-936E-02F1B5CFD56E Q43246318-B08A3190-9BA0-4805-A157-23AFC0F3CAF4 Q50117850-A8F58621-3126-4F31-87B7-18D6CAC9A5EB

P2860

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

http://www.wikidata.org/entity/Q24236589

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@ast

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en-gb

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@nl

type

label

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@ast

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en-gb

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@nl

prefLabel

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@ast

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en-gb

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@nl

P1433

Q24236589-652A2CD0-AE53-41C4-9EEF-15EDB6DF0B5B

P1476

Q24236589-E379FDB4-9B9C-4949-A348-6F324CC45920

P2093

Q24236589-463E3492-93CF-48C0-A884-10C0CB9F8FA4

Q24236589-BA5A2408-D868-45BB-AAC5-BEE11D1F8B00

Q24236589-DE40FB61-53C5-4E44-94C3-06BB969A105F

P2860

Q24236589-08CCC780-A7E6-4EFF-ADF3-CECB35F801CF

Q24236589-1FDE37CA-8249-4E1F-807B-AF4450BA59FB

Q24236589-2D464C9D-2E98-431E-9520-1BA3DD5B9329

Q24236589-335E099C-9A88-4150-B5DF-6E92C33BD5B1

Q24236589-3B35137D-B67C-4229-92E3-49A2CAAC7972

Q24236589-3B4F2F84-0B87-4B21-A8DB-A76B02C0F7F8

Q24236589-3F04E8D9-545E-404B-A5C1-28624D046029

Q24236589-4D66B311-3E15-4B38-8C0E-03791C4D080D

Q24236589-60DA928C-DA13-464E-8D8B-B0E93ECAB4B8

Q24236589-6DA6DA66-9F8F-4937-8FB2-982868FF8BBC

P31

Q24236589-0EA29FEB-1559-4D95-BCF2-FEBA8E6482E2

Q24236589-7f1a5dc4-bf10-4bf4-92ae-d73a9910a2e2

P356

Q24236589-DA221C4B-6335-44DF-9DF4-FB4FE7663C64

P50

Q24236589-198D4421-E97B-4244-BCC4-A46FC9D5A868

Q24236589-5201339D-AD2B-4E01-9CE0-24B6D1FCE4DE

Q24236589-74F3983B-89BB-49BD-B898-674CF61FC2F8

Q24236589-86E51188-344F-41C7-AFF1-926A98D1E3E6

Q24236589-BFEB6DA7-DDA5-4688-A8D8-038A368CF5F4

Q24236589-EBD75FCC-8AAA-41B9-940E-23A2466FF615

P577

Q24236589-ABA633E5-8D8D-4E5B-A7E3-03D10787E0B8

P5875

Q24236589-B92FED06-2111-4CD5-BBEC-42BCE5365701

P698

Q24236589-E8C32437-CEEB-4DF0-9301-B80A2AAE1ACC

P921

Q24236589-15029328-B33C-4B44-9587-BFD133335913

Q24236589-B9C85C12-6A65-4A7B-896C-FF2A9FFB8797

P356

14651858.CD007110.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

@en

P2093

Christine Herbst

http://www.w3.org/2001/XMLSchema#string

Fareed Ahmed Rehan

http://www.w3.org/2001/XMLSchema#string

Holger Schulz

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy, radiotherapy and combined modality for Hodgkin's disease, with emphasis on second cancer risk

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood

Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence.

Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's

Calculating the number needed to treat for trials where the outcome is time to an event

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

P31

scholarly article

P356

10.1002/14651858.CD007110.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

Corinne Brillant

P577

2011-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49842842

http://www.w3.org/2001/XMLSchema#string

P698

21328291

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy